ARTHRITIS & RHEUMATOLOGIC CONDITIONS
There are over one hundred types of arthritis alone and numerous other autoimmune conditions that affect different regions of the body. According to a recent biotechnology medicines in development report:
- Autoimmunity is the underlying cause of more than 100 serious, chronic illnesses, targeting women 75 percent of the time.
Arthritic conditions commonly present with joint swelling, pain, stiffness and decreased range of motion. Each of these symptoms can fluctuate in severity, frequency, and duration. Chronic pain can contribute to a decline in daily activities and quality of life. Some types of arthritis also affect the heart, eyes, lungs, kidneys and skin as well as the joints.
Medical treatment for mild or moderate arthritic conditions can include: oral medications, physical therapy, rest balanced with exercise, a healthy diet with weight management and avoiding excessive repetitive movements.
We treat many types of inflammatory and autoimmune conditions with biologic medications at ARISE infusion therapy centers.
Conditions treated can include:
Ankylosing Spondylitis is a rare autoimmune disorder affecting between 0.2 – 0.5 % of the general US population. It belongs to a group of diseases known as spondyloarthopathies. Spondyloarthropathies and Ankylosing Spondylitis in particular are more commonly seen in men between the ages of 20 and 40, although they can affect anyone regardless of age or gender.
AS, is a form of arthritis that primarily affects the spine, although other joints can be involved. This disease is due to Inflammation, more commonly with the spinal joints (vertebrae) develop that can lead to severe, chronic pain and discomfort. It is not a mechanical form of arthritis. In more advanced cases this inflammation can lead to ankylosis — new bone formation in the spine — causing sections of the spine to fuse in a fixed, immobile position.
It is typically characterized by:
- Low back pain – tends to be worse in the morning upon awakening and improves with activity
- Inflammation of the eyes, skin, peripheral joints, soft tissue or gastrointestinal tract
In a minority of individuals, pain does not start in the lower back, or even the neck, but in a peripheral joint such as the hip, ankle, elbow, knee, heel, or shoulder. This pain is commonly caused by enthesitis, inflammation of the site where a ligament or tendon attaches to bone.
Diagnosing disorders like AS can prove especially challenging as there are limited blood tests and imaging studies that can effectively evaluate patients with the condition. HLA B27 testing can be helpful in identifying those patients with back pain who may be at an increased risk of developing AS, and X-rays and magnetic resonance imaging (MRI) can help to look for joint damage associated with inflammation. Rheumatologists use a combination of blood tests, imaging studies, and your clinical history to arrive at a diagnosis of Ankylosing Spondylitis, and once the diagnosis is established he / she will help to determine appropriate therapy.
Use of anti-inflammatory medications (NSAIDS) and biologic medications which can be given as an infusion or an injection.
Infusion treatment medications include:
Additional information about Spondyloarthritis can be found here: LINK
Gout is an ancient disease, with its earliest descriptions dating to the time of Hippocrates. It is a painful affliction of the joints caused by deposits of crystals derived from uric acid. There are few disorders as painful as gout, turning those in the throes of an acute attack into a state of helplessness.
Attacks often occur as severe flare-ups typically in the feet and ankles:
Early on in the course of this disease, flare-ups occur infrequently, last a week or so, and resolve on their own or with the help of medications that fight inflammation.
Over time, attacks become more frequent, last longer and involve an increasing number of joints. Eventually, if not controlled, gout sufferers may develop persistent joint pain, swelling, deformity and disability. In the most severe cases, lumps composed of crystalline uric acid form on the joints and in other tissues. These lumps, called tophi, can be quite disfiguring and may interfere with ordinary joint function.
The management of gout involves two important steps.
- The first is to control the severe attacks by inhibiting inflammation with medications like colchicine, ibuprofen or naproxen.
- The second, as attacks become more frequent, is to mobilize and eliminate the uric acid derived crystals from the joints and surrounding tissues. In essence, first fix the pain and then clear the body of excess amounts of uric acid.
In rare cases, patients may need intravenous treatment with a uric acid lowering agent called pegloticase (Krystexxa). Working with a rheumatologist is the best way to determine the right therapy for patients with gout.
Infusion treatment medications include:
Additional information about Gout can be found here: LINK
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Systemic lupus erythematosus (SLE), or lupus, is a systemic autoimmune condition that can affect any part of the body. Autoimmune conditions are illnesses that occur when the body’s cells and tissues are attacked by its own immune system resulting in inflammation and tissue damage. Patients with lupus produce abnormal antibodies in their blood targeting tissues (autoantibodies) as opposed to foreign infectious agents.
Patients present with a myriad of complaints and symptoms; it can affect the skin, heart, lungs, kidneys, joints, and/or nervous system. When localized to the skin, without internal disease, it is called discoid lupus. Only when internal organs are involved is the condition referred to as systemic lupus erythematosus.
Who gets lupus?
Lupus is predominantly a disease of women. It may present at any age, although its peak incidence is during the childbearing years, between 15 and 45, at which time the female-to- male ratio climbs, reaching a peak ratio of approximately 12 :1. It occurs worldwide, although it is likely under-recognized and under- diagnosed in developing countries.
In the U.S., lupus is most prevalent among those of non-caucasian descent, with those of African heritage most affected.
Patients often report:
- Low- grade-fever
- Loss of appetite
- Muscle/ joint aches
- Sores in the mouth and nose
- Facial rash over the bridge of their nose (“butterfly rash”)
- Unusual sensitivity to sunlight
- Inflammation of the lining that surrounds the lungs and the heart
- Poor circulation to the fingers and toes with cold exposure (Raynaud’s phenomenon).
Complications may occur depending on the organ affected and the severity of the disease. Given its heterogeneous presentation, no single test can confirm and establish its diagnosis. A physician who specializes in lupus (rheumatologist) will evaluate the patient and make this clinical diagnosis.
Lupus is a chronic condition, and there is no cure yet available. However, in many cases patients can achieve remission of symptoms with prompt, appropriate treatment. Currently, there are both oral and intravenous therapies for lupus, all of which serve to control the body’s overactive immune response. Rheumatologists and patients work together to determine appropriate therapy based on the individual’s symptoms.
Infusion treatment medications include:
- Solu-Medrol (IV Steroid)
Additional information about Lupus can be found here: LINK
The inflammatory myopathies are a group of disorders that share a common feature of immune-mediated muscle injury. Clinical distinctions between these conditions suggest that different pathogenic processes underlie each of the following inflammatory myopathies subtypes:
- Necrotizing Autoimmune Myositis
- Inclusion Body Myositis
The cause of these inflammatory myopathies stems from an autoimmune reaction to the muscle tissue in genetically susceptible people. Precipitating factors that may be eliciting the event may include:
- Muscle injury
- Hormonal imbalances and electrolyte imbalances
Pathologic changes include:
- Cellular damage and atrophy
- Variable degrees of inflammation
- Muscles in the hands, feet, and face are affected less than other skeletal muscles
- Involvement of muscles in the pharynx and upper esophagus and occasionally the heart.
Inflammatory myositis is more common in African-Americans compared to caucasians and in woman as compared to men. Polymyositis primarily affects adults in their 30’s to 50’s. Dermatomyositis commonly affects children ages 5-15 and adults ages 45-65. Myositis can occur in combination with other autoimmune diseases. The exact cause is unknown, but we do know that it is an autoimmune disease (the body’s own immune system attacks the muscles) and in some cases the skin.
Myositis is characterized by the onset of chronic, severe weakness in muscles close to the trunk – the upper arms/shoulders, thighs and sometimes the neck. Weakness is due to muscle inflammation and subsequent muscle damage. While weakness is the most prominent symptom, muscle soreness can also occur. Patients may notice difficulty getting out of a chair, putting things away in overhead cabinets, or trouble climbing stairs due to weakness rather than pain.
Other symptoms can include:
- Shortness of breath from lung inflammation
- Joint pain
- Raynaud’s syndrome (finger color changes and numbness in cold weather)
- Trouble swallowing
Patients with dermatomyositis often develop:
- Several different kinds of rashes including one on the hands (Gottron’s papules)
- A violet discoloration or swelling around the eyes (heliotrope)and/or across the back and chest (shawl rash). This rash is worsened by sun exposure.
The diagnosis of inflammatory myositis relies on the history (e.g. how fast are the symptoms progressing?), physical exam, lab tests (e.g. how high are the muscle enzymes or tests that measure levels of muscle inflammation in the blood?), imaging such as MRI of the thigh muscles that can reveal muscle inflammation, nerve conduction studies and a muscle biopsy. The above results will help your rheumatologist (sometimes working with a neurologist) to exclude other diseases that can cause muscle weakness and thereby mimic inflammatory myopathies. Such mimickers include:
- Thyroid disease
- Toxin-induced myopathies (e.g. associated with the use of cholesterol lowering medications called statins)
- Neuromuscular disorders (e.g. muscular dystrophy)
- Genetic conditions such as metabolic myopathies (e.g. McArdle’s, mitochondrial myopathies)
It is important to establish the correct cause of the muscle weakness because each type of myositis is treated differently, and each has a different prognosis. Importantly, polymyositis and dermatomyositis can be associated with cancer. Your doctor will take a thorough history to make sure you are up-to-date with age-appropriate cancer screening (e.g. colonoscopy if you are over age 50).
The initial treatment for inflammatory myopathies is steroids taken by mouth and sometimes intravenously, depending on how severe symptoms are at diagnosis. No other medication works as quickly. The eventual goal is to taper the steroids slowly and substitute a medication that is safer to take in the long term such as mycophenolate mofetil or azathioprine.
In severe cases of myositis, especially when the muscles used for swallowing are impacted, we sometimes use intravenous immunoglobulin, or IVIG, a medication given monthly by infusion.
Physical therapy is also an important part of myositis treatment to help patients regain strength.
Infusion treatment medications include:
- Rituximab (Rituxan, Truxima)
- Intravenous Immunoglobulin
Additional information about Myopathies can be found here: LINK
On average, psoriatic arthritis affects about 30% of patients who have psoriasis and generally occurs about 9 to 10 years after the onset of psoriasis. Often the diagnosis is delayed because patients with psoriasis are not aware that arthritis can develop as a result of their skin disease. Even some health care professionals are not aware of all the potential complications that can occur in patients with psoriasis. A delay in diagnosis is problematic because studies have shown that damage to the joints can occur in some patients when appropriate treatment is not started promptly.
How psoriatic arthritis differs from other forms of arthritis:
Psoriatic arthritis is an autoimmune disorder, unlike osteoarthritis which develops primarily as a result of “wear and tear” on the joints. This means that, as with rheumatoid arthritis (RA), the immune system erroneously attacks the joints causing inflammation and damage. However, psoriatic arthritis falls into a group of disorders that is distinct from RA, known as the “seronegative spondyloarthropathies” or SPA, which share similar or overlapping features.
This group includes psoriatic arthritis, ankylosing spondylitis, arthritis associated with inflammatory bowel disease such as ulcerative colitis or Crohn’s disease, and reactive arthritis (arthritis that occurs secondary to an infection such as food poisoning or bacterial infection). These disorders share some genetic and clinical features, and may share some biologic characteristics that lead to their development.
The diagnosis of psoriatic arthritis is based on symptoms and findings in the musculoskeletal system of a patient with current or past psoriasis or a family history of psoriasis. Joint symptoms typically include swelling, redness and warmth of a few or many joints, often in an asymmetric fashion.
What is frequently different about psoriatic arthritis when compared to RA is prominent involvement of tendons and “entheses,” the area where a tendon or ligament attaches to bone. “Enthesitis” is present in many common conditions such as tennis elbow, plantar fasciitis and Achilles tendonitis. When these problems are occurring repetitively or in a chronic, non-healing fashion in a patient with psoriasis, the diagnosis of psoriatic arthritis should be considered.
Another common feature of psoriatic arthritis is dactylitis, often called “sausage digit.” This is a very painful and sometimes disabling problem which involves swelling of an entire finger or toe. We now know that dactylitis is due to swelling and inflammation of all the tissues within a digit including the joints, tendons, entheses and bone.
The spine can be involved in about 40 percent of patients, but it is rare for the spine to be the only area involved in psoriatic arthritis. Spine involvement is felt as inflammatory-type back pain. Inflammatory back pain is different than routine mechanical back pain in that it is slow as opposed to abrupt in onset, and gets better with activity and worse with rest. Inflammatory back pain frequently awakens sufferers from sleep at night.
Once the diagnosis is made, a patient’s condition is characterized as mild, moderate or severe based on disease activity assessed in all five areas of involvement in psoriatic arthritis (PsA). These areas include: the severity of skin disease, arthritis, back pain/spine involvement, dactylitis and enthesitis.
Psoriatic arthritis can also increase risk of cardiovascular complications (hypertension, heart attack and stroke).
Psoriatic arthritis is a potentially progressive disorder that not only can affect skin, joints, tendons and spine, but also can increase the risk of heart attack and stroke. Early recognition of this condition that allows appropriate treatment to begin is essential for relieving ongoing symptoms and possibly preventing future damage and disability.
Treatment is prescribed based on the severity of the disease, with milder therapies for mild cases and stronger medicines for severe disease that interferes with function.
Treatment may include non-medical interventions such as physical therapy and exercise. Weight loss is important for many patients with PsA, as increased weight has been shown to not only increase the risk of developing this disease, but also to decrease effectiveness of medicines.
Prescribed medications may include non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen), standard disease-modifying antirheumatic drugs (DMARDs) such as sulfasalazine, methotrexate and leflunamide) and biologic therapies such as Enbrel, Humira, Remicade, Cimzia, Simponi, Stelara, Otezla and Cosentyx.
Biologic agents are medications that interfere with inflammatory activity in the body. These agents help with the symptoms of both psoriasis and arthritis and some may help stop progression of the disease. The possibility of serious side effects exists with these and all medications, and should be discussed carefully with a rheumatologist to fully understand the risks and benefits before starting any new therapy. New biologic agents are also in clinical trials and will be available for general use for psoriatic arthritis in the near future.
Additional information about Psoriatic Arthritis can be found here: LINK
RHEUMATOID ARTHRITIS (RA)Overview
What exactly is rheumatoid arthritis (RA) and what can be done about it? Rheumatoid arthritis is the most common cause of autoimmune arthritis. It is characterized by inflammation in joints created by the immune system. Usually the immune system helps a person fight off infections, but in the case of RA, it attacks the joints and other tissues. The cause is unknown.
- Joints of the hands and feet are most frequently stiff, sore and sometimes swollen. Other joints and the neck can be involved.
- Symmetrical in body such as same finger on each hand.
- Morning stiffness typically lasts at least a half hour.
- Dry mouth and dry eye.
- Sensations of pins & needles.
- Hand bump on the finger or swelling.
- Skin lumps or redness.
Rheumatologists – physicians trained in musculoskeletal and autoimmune diseases – can ask detailed questions and order lab tests, xrays and other tests if needed. This evaluation can distinguish RA from more common “mechanical” joint pains (wear and tear, injuries, and overuse) and other ailments such as lupus, fibromyalgia, gout, carpal tunnel syndrome, and Lyme disease.Treatment
There is no specific treatment that works best for everyone with rheumatoid arthritis, so the strategy is to “treat to target”. A doctor and patient will discuss the best initial therapy. Most often this will be a “DMARD” (disease modifying anti-rheumatic drug). If RA has not improved enough once the drug has “kicked in”, then therapy can be augmented with other medicines. Several different kinds of medications can be used, ranging from pills to specialized home injections and in-office infusions. The process of getting RA under control may take 1 to 2 years; meanwhile anti-inflammatory treatments can help reduce pain and let people get back to their work, hobbies and lifestyle.
- First Line Medications:
- Second Line Medications:
- Physical Therapy & Exercise
Overall, rheumatoid arthritis is a very treatable disease. Specialized medications used in a “treat to target” strategy can prevent joint damage and disability. But there is no known cure for RA. It is hoped that future clinical research will identify not only new medicines, but also tools to predict which treatments will work in each specific person, and when medications might be stopped without provoking the disease to recur.
Additional information regarding Rheumatoid Arthritis can be found Here.
- Infliximab (Remicade, Inflectra, Renflexis, Avsola)
- Rituximab (Rituxan, Truxima)
- Simponi ARIA
Additional information about Rheumatoid Arthritis can be found here: LINK
Inflammatory arthritis describes a group of diseases caused by an overactive immune system. The most common symptoms are joint pain and stiffness. Affected joints may feel warm, swollen, and tender. But inflammatory arthritis can also affect other tissues in the body, including the lungs, heart, eyes, skin, and other organs.
But in someone with inflammatory arthritis, the immune response does not know when to stop. It turns on your body, attacking your own tissues instead of the foreign substance and causes continued inflammation. For this reason, inflammatory arthritis is known as an “autoimmune disease” − auto meaning “self” and “immune” because the immune system loses its ability to distinguish self from foreign.
Types of inflammatory arthritis include:
Juvenile idiopathic arthritis (JIA) affects young people under age 16, causing inflammation in the joints and sometimes in the spine and ligaments (tissues that connect bone to bone) that lasts for more than six weeks. Swelling or mobility problems, including a limp if the legs are affected, maybe the only signs of JIA. Some types of JIA cause eye inflammation that can occur without symptoms, so prompt diagnosis, treatment, and monitoring of JIA are vital to prevent permanent damage.
Still’s disease including Adult-Onset Still’s Disease (AOSD) is an autoinflammatory disorder that can be caused by having too much of or being too sensitive to certain proteins, including IL-1β, and can lead to symptoms such as fever, rash, headache, feeling very tired (fatigue), or painful joints and muscles. AOSD is a type of Still’s disease that develops after 16 years of age.
Systemic Juvenile Idiopathic Arthritis (SJIA) is an autoinflammatory disorder that can be caused by having too much of or being too sensitive to certain proteins, including IL-1β, and can lead to symptoms such as fever, rash, headache, feeling very tired (fatigue), or painful joints and muscles. SJIA is a type of Still’s disease.
- Cryopyrin-Associated Periodic Syndromes (CAPS) is a group of rare and genetic diseases that includes Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS).
- Familial Cold Autoinflammatory Syndrome (FCAS) is an autoinflammatory disease in a group of rare diseases called Cryopyrin-Associated Periodic Syndromes (CAPS). It is also known as FCAS.
- Muckle-Wells Syndrome (MWS) an autoinflammatory disease in a group of rare diseases called Cryopyrin-Associated Periodic Syndromes (CAPS). It is also known as MWS.
- Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS) is a rare and chronic autoinflammatory disease belonging to a group of diseases called Periodic Fever Syndromes.
- Hyperimmunoglobulin D Syndrome (HIDS) also known as Mevalonate Kinase Deficiency (MKD) in adult and pediatric patients
- Familial Mediterranean Fever (FMF) is a rare and chronic autoinflammatory disease belonging to a group of diseases known as Periodic Fever Syndromes.
Additional information about AOSD can be found here: LINK
Additional information about CAPS can be found here: LINK
Additional information about FMF can be found here: LINK
Additional information about JIA can be found here: LINK
Additional information about TRAPS can be found here: LINK
Additional information about HIDS/MKD can be found here: LINK
Vasculitis literally means inflammation of the blood vessels. It is defined by the presence of inflammatory white blood cells in the vessel walls resulting in reactive damage and loss of vessel integrity which can lead to rashes, bleeding and tissue or organ damage. Vasculitis is a rare condition and can be a primary process, or secondary to another underlying disease or autoimmune condition. Vasculitis can affect people of any age, but some types occur more in certain age groups and ethnicities. Classically, they are categorized by the predominant sizes of the blood vessels that are affected, and also by the presence or absence of antineutrophil cytoplasmic antibodies (ANCA), which can be detected with specific blood testing.
Patients often report:
- Large vessel vasculitidies include Takayasu Arteritis and Giant Cell Arteritis (GCA), or Temporal Arteritis (which occurs in about 15% of patients with Polymyalgia Rheumatica).
- Medium sized vessel vasculitidies include Polyarteritis Nodosa (PAN), Kawasaki disease, and primary CNS Vasculitis.
- Small vessel vasculitidies include Wegener’s (now named Granulomatosis with Polyangiitis or GPA), Microscopic Polyangiitis, Churg-Strauss.
- Vasculitis can be secondary to conditions like Lupus and Rheumatoid Arthritis or occur after e exposure to medications, or infections like Hepatitis B and C, HIV, CMV, EBV and Parvovirus.
Symptoms are extremely varied, depending on the cause and which organ is involved; they can range from very mild to quite severe.
Diagnostic evaluation should consider age and gender, include a detailed history, including drug use, and infectious disease exposures. General labs should be obtained to identify which type of disorder is present and the degree of organ involvement if any.
Additional testing can be directed by a rheumatologist, and depending on pretest probability can include:
- ANA (Anti-nuclear antibodies)
- Complement levels
Other useful tests sometimes include:
- EMG/ NCS (electromyography/nerve conduction studies),
- Imaging including MRI/MRA or ultrasound
- Tissue biopsy
Treatment depends on the nature, severity and type of vasculitis, as well as what organs are affected and to what degree they are affected. For example, in mild hypersensitivity vasculitis due to a drug, discontinuing the offending drug may be adequate, along with antihistamines and observation.
However, for other vasculitidies that cause pulmonary, neurologic, or renal manifestations, aggressive treatment may be required, including:
- Corticosteroids (Prednisone)
- Immunosuppressive therapies including Methotrexate, Azathioprine, Cyclophosphamide and Rituximab
The goal of treatment is to induce remission, to minimize drug toxicity and to monitor for signs of recurrence.
Infusion treatment medications include:
Additional information about Vasculitis can be found here: LINK
Additional information about Wegner’s Vasculitis can be found here: LINK
GIANT CELL ARTERITIS (GCA)
Giant Cell Arteritis (GCA) is a common type of vasculitis, or blood vessel inflammation, seen mostly in older adults. Formerly called temporal arteritis, as it tends to affect the arteries located along the temples on the sides of the head. In GCA, arteries inflame, causing headache, blurred vision, pain in the shoulders or hips, jaw pain after chewing food, fever, pain in the scalp, and other symptoms.